Carboxylesterase and cholinesterase inhibition in rats. Abate and interaction with malathion.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002087:Butyrates; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000633:toxicity*; D002802:Cholinesterases / Q000378:metabolism; D004347:Drug Interactions; D004950:Esterases / Q000037:antagonists & inhibitors*; D006868:Hydrolysis; D008099:Liver / Q000201:enzymology; D008294:Malathion / Q000008:administration & dosage / Q000633:toxicity*; D008297:Male; D009946:Organothiophosphorus Compounds / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D013363:Submandibular Gland / Q000201:enzymology; D013386:Succinates; D014215:Triacetin; D014881:Water Supply
D002087:Butyrates; D002800:Cholinesterase Inhibitors; D009946:Organothiophosphorus Compounds; D013386:Succinates; D004950:Esterases; D002802:Cholinesterases; D008294:Malathion; D014215:Triacetin